AEHA
Aesther Healthcare Acquisition Corp. [AEHA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AEHA Stock Summary
In the News
AEHA Financial details
Company Rating
Neutral
Market Cap
364.37M
Income
-1.89M
Revenue
0
Book val./share
-1.77
Cash/share
0.18
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-13.83
Forward P/E
-
PEG
-
P/S
-
P/B
-5.63
P/C
22.11
P/FCF
-528
Quick Ratio
0.23
Current Ratio
0.29
Debt / Equity
-1.13
LT Debt / Equity
-
-
-
EPS (TTM)
-0.67
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
2194.12%
-
-
-
-
SMA20
-21.05%
SMA50
-19.9%
SMA100
-19.04%
Inst Own
100%
Inst Trans
0%
ROA
-2%
ROE
71%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
36.58M
Shs Float
3.72M
-
-
-
-
Target Price
-
52W Range
3.79-14.22
52W High
-71.57%
52W Low
+32.67%
RSI
21.02
Rel Volume
0.28
Avg Volume
180.5K
Volume
50.7K
Perf Week
-55.43%
Perf Month
-61.88%
Perf Quarter
-
Perf Half Y
-60.9%
-
-
-
-
Beta
-
-
-
Volatility
2.27%, 1.76%
Prev Close
-26.53%
Price
3.98
Change
-39.88%
AEHA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| Revenue per share | 0 | |
| Net income per share | -0.04 | |
| Operating cash flow per share | -0.06 | |
| Free cash flow per share | -0.06 | |
| Cash per share | 0.08 | |
| Book value per share | 7.96 | |
| Tangible book value per share | 7.96 | |
| Share holders equity per share | 7.96 | |
| Interest debt per share | 0 | |
| Market cap | 132.12M | |
| Enterprise value | 131.04M | |
| P/E ratio | -234.21 | |
| Price to sales ratio | 0 | |
| POCF ratio | -166.31 | |
| PFCF ratio | -166.31 | |
| P/B Ratio | 1.26 | |
| PTB ratio | 1.26 | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | -232.3 | |
| EV to operating cash flow | -164.96 | |
| EV to free cash flow | -164.96 | |
| Earnings yield | 0 | |
| Free cash flow yield | -0.01 | |
| Debt to equity | 0.03 | |
| Debt to assets | 0.03 | |
| Net debt to EBITDA | 1.91 | |
| Current ratio | 6.29 | |
| Interest coverage | 0 | |
| Income quality | 1.41 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 2.76 | |
| ROIC | -0.01 | |
| Return on tangible assets | -0.01 | |
| Graham Net | -0.18 | |
| Working capital | 1.3M | |
| Tangible asset value | 105.26M | |
| Net current asset value | -1.85M | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 0 | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -0.01 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.02 | -0.2 | -0.06 | -0.02 | -0.39 | |
| Operating cash flow per share | -0.27 | -0.03 | -0.07 | -0.01 | -0.12 | |
| Free cash flow per share | -0.27 | -0.03 | -0.07 | -0.01 | -0.12 | |
| Cash per share | 0.44 | 0.41 | 0.32 | 0.05 | 0.18 | |
| Book value per share | 40.08 | -0.7 | -0.76 | -0.21 | -1.77 | |
| Tangible book value per share | 40.08 | 39.88 | 39.82 | 9.9 | 39.58 | |
| Share holders equity per share | 40.08 | -0.7 | -0.76 | -0.21 | -1.77 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0.4 | |
| Market cap | 26.31M | 26.36M | 26.63M | 107.17M | 26.75M | |
| Enterprise value | 25.15M | 25.29M | 25.78M | 106.59M | 27.33M | |
| P/E ratio | -154.61 | -12.64 | -40.17 | -144.87 | -6.57 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -37.17 | -304.44 | -138.5 | -1.1K | -85.24 | |
| PFCF ratio | -37.17 | -304.44 | -138.5 | -1.1K | -85.24 | |
| P/B Ratio | 0.25 | -14.3 | -13.25 | -48.83 | -5.76 | |
| PTB ratio | 0.25 | -14.3 | -13.25 | -48.83 | -5.76 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -591.14 | -48.49 | -155.59 | -576.36 | -26.85 | |
| EV to operating cash flow | -35.53 | -292.02 | -134.11 | -1.09K | -87.09 | |
| EV to free cash flow | -35.53 | -292.02 | -134.11 | -1.09K | -87.09 | |
| Earnings yield | 0 | -0.02 | -0.01 | 0 | -0.04 | |
| Free cash flow yield | -0.03 | 0 | -0.01 | 0 | -0.01 | |
| Debt to equity | 0.03 | -1.84 | -1.62 | -1.67 | -1.13 | |
| Debt to assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | |
| Net debt to EBITDA | 27.32 | 2.06 | 5.1 | 3.12 | -0.57 | |
| Current ratio | 185.82 | 6.29 | 11.69 | 1.47 | 0.29 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 16.64 | 0.17 | 1.16 | 0.53 | 0.31 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.81 | 1.76 | 1.04 | 0.29 | 3.93 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | -0.01 | |
| Graham Net | -0.76 | -0.88 | -0.91 | -0.29 | -1.82 | |
| Working capital | 1.82M | 1.3M | 1.09M | 239.19K | -1.49M | |
| Tangible asset value | 105.78M | 105.26M | 105.09M | 104.91M | 103.89M | |
| Net current asset value | -1.33M | -1.85M | -2.06M | -2.91M | -4.64M | |
| Invested capital | 0 | 0 | 0 | 0 | -0.23 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 2.43K | 19.65K | 49.94K | 105.24K | 163.04K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0.28 | 0.08 | 0.08 | 0.22 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
AEHA Frequently Asked Questions
What is Aesther Healthcare Acquisition Corp. stock symbol ?
Aesther Healthcare Acquisition Corp. is a US stock , located in New york of Ny and trading under the symbol AEHA
What is Aesther Healthcare Acquisition Corp. stock quote today ?
Aesther Healthcare Acquisition Corp. stock price is $3.98 today.
Is Aesther Healthcare Acquisition Corp. stock public?
Yes, Aesther Healthcare Acquisition Corp. is a publicly traded company.
Company Profile
- Volume Average 180.5K
- Market Capitalization 364.37M
- CEO Mr. Surendra K. Ajjarapu
- Headquarters New York,NY,US
- IPO Date 2021-11-05
Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.
